{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:36:04Z","timestamp":1793306164050,"version":"4.5.0"},"reference-count":240,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2020.00494","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T16:28:06Z","timestamp":1591720086000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":290,"title":["Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs"],"prefix":"10.3389","volume":"14","author":[{"given":"Saba","family":"Naqvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archna","family":"Panghal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J. S.","family":"Flora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0696-696","article-title":"Intrathecal delivery of cntf using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients.","volume":"2","author":"Aebischer","year":"1996","journal-title":"Nat. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.3109\/10717544.2014.941076","article-title":"Pnipam nanoparticles for targeted and enhanced nose-to-brain delivery of curcuminoids: Uplc\/esi-q-tof-ms\/ms-based pharmacokinetics and pharmacodynamic evaluation in cerebral ischemia model.","volume":"23","author":"Ahmad","year":"2016","journal-title":"Drug Deliv."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.2147\/IJN.S210876","article-title":"Recent expansions of novel strategies towards the drug targeting into the brain.","volume":"14","author":"Alexander","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"B4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.euroneuro.2006.05.003","article-title":"Comparative efficacy of liposome-entrapped amiloride and free amiloride in animal models of seizures and serum potassium in mice.","volume":"17","author":"Ali","year":"2007","journal-title":"Eur. Neuropsychopharm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1517\/17425247.3.1.139","article-title":"Polymeric micelles for drug delivery.","volume":"3","author":"Aliabadi","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S45639","article-title":"Substrates coated with silver nanoparticles as a neuronal regenerative material.","volume":"9","author":"Alon","year":"2014","journal-title":"Int. J Nanomed."},{"key":"B7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2147\/IJN.S52236","article-title":"Nanoscale drug delivery systems and the blood\u2013brain barrier.","volume":"9","author":"Alyautdin","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"B8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.nano.2019.01.010","article-title":"Poly(propylene imine) dendrimers with histidine-maltose shell as novel type of nanoparticles for synapse and memory protection.","volume":"17","author":"Aso","year":"2019","journal-title":"Namomed. Nanotechnol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"E536","DOI":"10.1208\/pt060367","article-title":"Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of acidic anti-inflammatory active ingredient.","volume":"6","author":"Asthana","year":"2005","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"B10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1517\/17425240902758188","article-title":"Challenges and opportunities in cns delivery of therapeutics for neurodegenerative diseases.","volume":"6","author":"Barchet","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"B11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae \u2013 the first FDA-approved nano-drug: lessons learned.","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control Rel."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease.","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jconrel.2008.04.013","article-title":"Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers.","volume":"130","author":"Batrakova","year":"2008","journal-title":"J. Control Rel."},{"key":"B14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.nano.2008.06.002","article-title":"Emerging nanopharmaceuticals.","volume":"4","author":"Bawarski","year":"2008","journal-title":"Nanomedicine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.nurt.2009.01.018","article-title":"Nanotechnology for delivery of drugs to the brain for epilepsy.","volume":"6","author":"Bennewitz","year":"2009","journal-title":"Neurotherapeutics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.nurt.2009.04.004","article-title":"Novel drug delivery strategies in neuro-oncology.","volume":"6","author":"Bidros","year":"2009","journal-title":"Neurotherapeutics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.addr.2007.04.011","article-title":"Solid lipid nanoparticles for targeted brain drug delivery.","volume":"59","author":"Blasi","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1007\/s11095-016-1958","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date.","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2217\/nnm.09.67","article-title":"Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution.","volume":"5","author":"Bond\u00ec","year":"2010","journal-title":"Nanomedicine"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11020084","article-title":"Nanoemulsions for \u201cNose-to-Brain\u201d drug delivery.","volume":"11","author":"Bonferoni","year":"2019","journal-title":"Pharmaceutics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"22480","DOI":"10.1073\/pnas.0911503106","article-title":"Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms.","volume":"106","author":"Bradford","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B22","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1124\/jpet.102.039669","article-title":"Poly (ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting.","volume":"303","author":"Brigger","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1416","article-title":"Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials.","volume":"9","author":"Caster","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1080\/17425247.2019.1690452","article-title":"In vivo biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles.","volume":"12","author":"Cayero-Otero","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"B25","year":"2017","journal-title":"FDA Approved Drugs."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1002\/jbm.a.36141","article-title":"Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.","volume":"105","author":"Chakraborty","year":"2017","journal-title":"J. Biomed. Mater. Res. A"},{"key":"B27","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.addr.2011.03.011","article-title":"Production methods for nanodrug particles using the bottom-up approach.","volume":"63","author":"Chan","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1007\/s11095-008-9615-9612","article-title":"Solid lipid nanoparticles enhance the delivery of the hiv protease inhibitor, atazanavir, by a human brain endothelial cell line.","volume":"25","author":"Chattopadhyay","year":"2008","journal-title":"Pharm. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jconrel.2012.11.005","article-title":"Polymeric hydrogels for oral insulin delivery.","volume":"165","author":"Chaturvedi","year":"2013","journal-title":"J. Control Rel."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060860","article-title":"Egfp-egf1-conjugated plga nanoparticles for targeted delivery of sirna into injured brain microvascular endothelial cells for efficient rna interference.","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"9516","DOI":"10.1021\/acsami.7b01171","article-title":"Small-sized mPEG-PLGA nanoparticles of schisantherin A with sustained release for enhanced brain uptake and anti-Parkinsonian activity.","volume":"9","author":"Chen","year":"2017","journal-title":"ACS Appl. Mater. Interf."},{"key":"B32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3109\/08982104.2014.899369","article-title":"Multifunctional liposomes for nasal delivery of the anti-alzheimer drug tacrine hydrochloride.","volume":"24","author":"Corace","year":"2014","journal-title":"J. Liposome Res."},{"key":"B33","first-page":"25","article-title":"Edaravone (Radicava): a novel neuroprotective agent for the treatment of amyotrophic lateral sclerosis.","volume":"43","author":"Cruz","year":"2018","journal-title":"P T"},{"key":"B34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ejpb.2004.07.009","article-title":"Novel d-penicillamine carrying nanoparticles for metal chelation therapy in alzheimer\u2019s and other cns diseases.","volume":"59","author":"Cui","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/jps.20357","article-title":"Double-coated poly (butylcynanoacrylate) nanoparticulate delivery systems for brain targeting of dalargin via oral administration.","volume":"94","author":"Das","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1021\/mp700086j","article-title":"Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability.","volume":"5","author":"Dhanikula","year":"2008","journal-title":"Mol. Pharm."},{"key":"B37","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.2042-7158.2010.01225.x","article-title":"Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery.","volume":"63","author":"Dhawan","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118814","article-title":"Dendrimers in the context of nanomedicine.","volume":"573","author":"Dias","year":"2020","journal-title":"Int. J. Pharm."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.2174\/1389201015666140608143719","article-title":"Nanobiotechnology-based drug delivery in brain targeting.","volume":"14","author":"Dinda","year":"2013","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3233\/JAD-2012-112141","article-title":"Neuronal uptake and neuroprotective effect of curcumin-loaded plga nanoparticles on the human SK-N-SH cell line.","volume":"30","author":"Doggui","year":"2012","journal-title":"J. Alzheimer Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/s1353-8020(00)00064-x","article-title":"Fullerene-based antioxidants and neurodegenerative disorders.","volume":"7","author":"Dugan","year":"2001","journal-title":"Parkinsonism. Relat. Disord."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.addr.2005.09.019","article-title":"Dendrimer biocompatibility and toxicity.","volume":"57","author":"Duncan","year":"2005","journal-title":"Adv. Drug Deliv Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.freeradbiomed.2011.06.006","article-title":"Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia.","volume":"51","author":"Estevez","year":"2011","journal-title":"Free Radic Biol. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"GBD. 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"18","author":"Feigin","year":"2019","journal-title":"Lancet Neurol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.leukres.2012.07.006","article-title":"Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine: daunorubicin, in patients with advanced leukemia.","volume":"36","author":"Feldman","year":"2012","journal-title":"Leuk. Res."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1208\/ps050432","article-title":"Pharmacokinetics of paclitaxel-containing liposomes in rats.","volume":"5","author":"Fetterly","year":"2003","journal-title":"AAPS Pharm. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s002329900434","article-title":"Blood-brain barrier permeation: molecular parameters governing passive diffusion.","volume":"165","author":"Fischer","year":"1998","journal-title":"J. Membrane Biol."},{"key":"B48","year":"2017","journal-title":"Our Product: Zilretta (triamcinolone acetonide extended. (release)Formulation)."},{"key":"B49","year":"2017","journal-title":"Novel drug approvals for 2017."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2015.09.020","article-title":"Treatment of stroke with liposomal neuroprotective agents under cerebral ischemia conditions.","volume":"97","author":"Fukuta","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1007\/s11095-013-1122-1124","article-title":"Targeted delivery of nano-therapeutics for major disorders of the central nervous system.","volume":"30","author":"Gao","year":"2013","journal-title":"Pharm. Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ijpharm.2005.11.040","article-title":"Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.","volume":"310","author":"Gao","year":"2006","journal-title":"Int. J. Pharm."},{"key":"B53","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jconrel.2012.03.013","article-title":"Drug nanocrystals: in vivo performances.","volume":"160","author":"Gao","year":"2012","journal-title":"J. Control Rel."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1158\/1535-7163.MCT-06-0289","article-title":"A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats.","volume":"5","author":"Garcion","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1073\/pnas.0409336102","article-title":"Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for alzheimer\u2019s disease.","volume":"102","author":"Georganopoulou","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B56","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3390\/pharmaceutics6040557","article-title":"Smuggling drugs into the brain: an overview of ligands targeting transcytosis for drug delivery across the blood\u2013brain barrier.","volume":"6","author":"Georgieva","year":"2014","journal-title":"Pharmaceutics"},{"key":"B57","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/s0165-0173(01)00102-103","article-title":"Molecular and cellular permeability control at the blood-brain barrier.","volume":"36","author":"Gloor","year":"2001","journal-title":"Brain Res. Brain Res. Rev."},{"key":"B58","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1021\/mp3003946","article-title":"Self-assembling modified \u03b2-cyclodextrin nanoparticles as neuronal sirna delivery vectors: focus on huntington\u2019s disease.","volume":"10","author":"Godinho","year":"2013","journal-title":"Mol. Pharm."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.2174\/138920112803341770","article-title":"Perspectives on brain-targeting drug delivery systems.","volume":"13","author":"Guo","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.addr.2007.04.005","article-title":"Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug.","volume":"59","author":"Hanafy","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1208\/s12248-016-9961-7","article-title":"Nanomedicines: from bench to bedside and beyond.","volume":"18","author":"Havel","year":"2016","journal-title":"AAPS J."},{"key":"B62","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.biomaterials.2010.09.002","article-title":"Pegylated poly (amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors.","volume":"32","author":"He","year":"2011","journal-title":"Biomaterials"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/351031","article-title":"Application of nanoparticles on diagnosis and therapy in gliomas.","volume":"2013","author":"Hern\u00e1ndez-Pedro","year":"2013","journal-title":"Biomed. Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2147\/IJN.S30725","article-title":"Liposomes and nanotechnology in drug development: focus on ocular targets.","volume":"8","author":"Honda","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003651","article-title":"Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.","volume":"4","author":"Hrkach","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jconrel.2012.05.038","article-title":"Design and characterization of a novel amphiphilic chitosan nanocapsule-based thermo-gelling biogel with sustained in vivo release of the hydrophilic anti-epilepsy drug ethosuximide.","volume":"161","author":"Hsiao","year":"2012","journal-title":"J. Control. Release"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/smll.201200715","article-title":"Carbon nanotube rope with electrical stimulation promotes the differentiation and maturity of neural stem cells.","volume":"8","author":"Huang","year":"2012","journal-title":"Small"},{"key":"B68","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2217\/fnl.13.40","article-title":"Inflammation and human cerebral aneurysms: current and future treatment prospects.","volume":"8","author":"Hudson","year":"2013","journal-title":"Future Neurol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"336","DOI":"10.2174\/1389200215666141125142605","article-title":"A synopsis of nano-technological approaches toward anti-epilepsy therapy: present and future research implications.","volume":"16","author":"Jabir","year":"2015","journal-title":"Curr. Drug Metab."},{"key":"B70","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000101884","article-title":"Nanobiotechnology-based drug delivery to the central nervous system.","volume":"4","author":"Jain","year":"2007","journal-title":"Neurodegen. Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.biomaterials.2013.10.075","article-title":"Multimodal nanoprobes to target cerebrovascular amyloid in alzheimer\u2019s disease brain.","volume":"35","author":"Jaruszewski","year":"2014","journal-title":"Biomaterials"},{"key":"B72","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/jps.10272","article-title":"Carbendazim: disposition, cellular permeability, metabolite identification, and pharmacokinetic comparison with its nanoparticle.","volume":"92","author":"Jia","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/1097-4547(20001115)62:4<600::AID-JNR15>3.0.CO;2-F","article-title":"Polyhydroxylated c60, fullerenols, as glutamate receptor antagonists and neuroprotective agents.","volume":"62","author":"Jin","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jconrel.2005.11.013","article-title":"Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs.","volume":"111","author":"Jinno","year":"2006","journal-title":"J. Control Rel."},{"key":"B75","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s13346-014-0208-209","article-title":"Gelatin nanoparticles enhance the neuroprotective effects of intranasally administered osteopontin in rat ischemic stroke model.","volume":"4","author":"Joachim","year":"2014","journal-title":"Drug Deliv. Transl. Res."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-6-1","article-title":"The burden of multiple sclerosis: a community health survey.","volume":"6","author":"Jones","year":"2008","journal-title":"Health Qual. Life Outcomes"},{"key":"B77","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1007\/s12274-018-2104-y","article-title":"Curcumin-loaded polymeric nanoparticles for neuroprotection in neonatal rats with hypoxic-ischemic encephalopathy.","volume":"11","author":"Joseph","year":"2018","journal-title":"Nano Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0014-5793(89)81689-81688","article-title":"The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles.","volume":"258","author":"Kabanov","year":"1989","journal-title":"FEBS Lett."},{"key":"B79","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ejpb.2013.02.005","article-title":"Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats.","volume":"85","author":"Kakkar","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B80","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(14)61393-61393","article-title":"Parkinson\u2019s disease.","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1021\/mp1001872","article-title":"Capping methotrexate \u03b1-carboxyl groups enhances systemic exposure and retains the cytotoxicity of drug conjugated PEGylated polylysine dendrimers.","volume":"8","author":"Kaminskas","year":"2011","journal-title":"Mol. Pharm."},{"key":"B82","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nano.2011.05.013","article-title":"A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems.","volume":"8","author":"Kaminskas","year":"2012","journal-title":"Nanomedicine"},{"key":"B83","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1146\/annurev.micro.52.1.627","article-title":"How do animal DNA viruses get to the nucleus?","volume":"52","author":"Kasamatsu","year":"1998","journal-title":"Annu. Rev. Microbiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s10637-011-9709-2","article-title":"Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer.","volume":"30","author":"Kato","year":"2012","journal-title":"Invest. New Drugs"},{"key":"B85","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jconrel.2007.12.018","article-title":"Potential of solid lipid nanoparticles in brain targeting.","volume":"127","author":"Kaur","year":"2008","journal-title":"J. Control Rel."},{"key":"B86","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ejps.2009.12.009","article-title":"Novel crystalline solid dispersion of tranilast with high photostability and improved oral bioavailability.","volume":"39","author":"Kawabata","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1211\/0022357011776423","article-title":"Sustained ocular delivery of tilisolol to rabbits after topical administration or intravitreal injection of lipophilic prodrug incorporated in liposomes.","volume":"53","author":"Kawakami","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4103\/2141-9248.133447","article-title":"Prospect of brain machine interface in motor disabilities: the future support for multiple sclerosis patient to improve quality of life.","volume":"4","author":"Khare","year":"2014","journal-title":"Ann. Med. Health Sci. Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","article-title":"The role of oxidative stress in neurodegenerative diseases.","volume":"24","author":"Kim","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1002\/elps.200600694","article-title":"Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and protein Lab-on-chipVR system.","volume":"28","author":"Kim","year":"2007","journal-title":"Electrophoresis"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1046\/j.1528-1157.2002.11202.x","article-title":"Effectiveness of muscimol-containing microparticles against pilocarpine-induced focal seizures.","volume":"43","author":"Kohane","year":"2002","journal-title":"Epilepsia"},{"key":"B92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajps.2013.07.001","article-title":"The endocytosis and intracellular fate of nanomedicines: implication for rational design.","volume":"8","author":"Kou","year":"2013","journal-title":"Asian J. Pharm. Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0169-409x(00)00122-8","article-title":"Nanoparticulate systems for brain delivery of drugs.","volume":"47","author":"Kreuter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B94","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/02652048.2012.692491","article-title":"Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (bbb).","volume":"30","author":"Kreuter","year":"2013","journal-title":"J. Microencapsul."},{"key":"B95","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/10611860290031877","article-title":"Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.","volume":"10","author":"Kreuter","year":"2002","journal-title":"J. Drug Targt."},{"key":"B96","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","article-title":"A review on alzheimer\u2019s disease pathophysiology and its management: an update.","volume":"67","author":"Kumar","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems.","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf. B Biointerf."},{"key":"B98","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1080\/10611860903112842","article-title":"Brain targeting of nerve growth factor using poly (butyl cyanoacrylate) nanoparticles.","volume":"17","author":"Kurakhmaeva","year":"2009","journal-title":"J. Drug Target"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1002\/jps.22469","article-title":"Lactoferrin-conjugated dendritic nanoconstructs for lung targeting of methotrexate.","volume":"100","author":"Kurmi","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jconrel.2006.02.014","article-title":"Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous p-glycoprotein inhibition.","volume":"112","author":"Lamprecht","year":"2006","journal-title":"J. Control Rel."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1517\/17425240903167942","article-title":"New strategies to deliver anticancer drugs to brain tumors.","volume":"6","author":"Laquintana","year":"2009","journal-title":"Exp. Opin. Drug Deliv."},{"key":"B102","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ejps.2012.11.004","article-title":"Oral bioavailability of cinnarizine in dogs: relation to SNEDDS droplet size, drug solubility and in vitro precipitation.","volume":"48","author":"Larsen","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201700313","article-title":"Dendrimers as powerful building blocks in central nervous system disease: headed for successful nanomedicine.","volume":"28","author":"Leiro","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"B104","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1166\/jnn.2014.8757","article-title":"Functional nanoparticles in targeting glioma diagnosis and therapies.","volume":"14","author":"Li","year":"2014","journal-title":"J. Nanosci. Nanotechno."},{"key":"B105","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/1061186X.2016.1184272","article-title":"Nano carriers for drug transport across the blood-brain barrier.","volume":"25","author":"Li","year":"2017","journal-title":"J. Drug Target"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1021\/bm201790s","article-title":"In vitro assessment of alkylglyceryl-functionalized chitosan nanoparticles as permeating vectors for the blood-brain barrier.","volume":"13","author":"Lien","year":"2012","journal-title":"Biomacromolecules"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2525967","article-title":"Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications.","volume":"2017","author":"Liu","year":"2017","journal-title":"Oxid Med. Cell Longev."},{"key":"B108","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/s0022-510x(98)00092-96","article-title":"Copper, iron and zinc in alzheimer\u2019s disease senile plaques.","volume":"158","author":"Lovell","year":"1998","journal-title":"J. Neurol Sci."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.4236\/jbnb.2011.225075","article-title":"Current state of nanoemulsions in drug delivery.","volume":"2","author":"Lovelyn","year":"2011","journal-title":"J. Biomater. Nanobiotechnol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0920-9964(95)00049-6","article-title":"Free radical pathology and antioxidant defense in schizophrenia: a review.","volume":"19","author":"Mahadik","year":"1996","journal-title":"Schizophrenia Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jconrel.2005.06.006","article-title":"Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.","volume":"107","author":"Manjunath","year":"2005","journal-title":"J. Control Rel."},{"key":"B112","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1080\/10611860600888850","article-title":"Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration.","volume":"14","author":"Manjunath","year":"2006","journal-title":"J. Drug Target."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1039\/c4nr05193a","article-title":"Ngf-conjugated iron oxide nanoparticles promote differentiation and outgrowth of pc12 cells.","volume":"7","author":"Marcus","year":"2015","journal-title":"Nanoscale"},{"key":"B114","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejpb.2010.11.015","article-title":"Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC\/D3 cell line.","volume":"77","author":"Markoutsa","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B115","doi-asserted-by":"publisher","first-page":"16288","DOI":"10.1073\/pnas.1210096109","article-title":"Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics.","volume":"109","author":"Marrache","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B116","first-page":"595","article-title":"Lipid-based colloidal carriers for peptide and protein delivery \u2013 liposomes versus lipid nanoparticles.","volume":"2","author":"Martins","year":"2007","journal-title":"Int. J. Nanomed."},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032616","article-title":"Curcumin loaded-plga nanoparticles conjugated with tet-1 peptide for potential use in alzheimer\u2019s disease.","volume":"7","author":"Mathew","year":"2012","journal-title":"PLoS One"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/sj.bjc.6602204","article-title":"Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin.","volume":"91","author":"Matsumura","year":"2004","journal-title":"Br. J. Cancer"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1073\/pnas.251662398","article-title":"Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery.","volume":"99","author":"Mcintosh","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B120","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s13346-012-0117-118","article-title":"Engineering triiodothyronine (t3) nanoparticle for use in ischemic brain stroke.","volume":"3","author":"Mdzinarishvili","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"key":"B121","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1242\/jeb.172.1.39","article-title":"The importance of being acid: the role of acidification in intracellular membrane traffic.","volume":"172","author":"Mellman","year":"1992","journal-title":"J. Exp. Biol."},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3390\/md17090515","article-title":"Chitosan Oleate Coated Poly Lactic-Glycolic Acid (PLGA) nanoparticles versus chitosan oleate self-assembled polymeric micelles, loaded with resveratrol.","volume":"17","author":"Miele","year":"2019","journal-title":"Mar. Drugs"},{"key":"B123","first-page":"252","article-title":"Drug delivery to the central nervous system: a review.","volume":"6","author":"Misra","year":"2003","journal-title":"J. Pharm. Pharm. Sci."},{"key":"B124","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1749-6632.2009.05108","article-title":"Advances in the treatment of neurodegenerative disorders employing nanotechnology.","volume":"1184","author":"Modi","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B125","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/jps.21082","article-title":"Engineering biodegradable polyester particles with specific drug targeting and drug release properties.","volume":"97","author":"Mohamed","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"B126","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/jbm.b.32888","article-title":"Development of poly (butylene succinate) microspheres for delivery of levodopa in the treatment of parkinson\u2019s disease.","volume":"101","author":"Mohanraj","year":"2013","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"B127","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s11095-011-0558-557","article-title":"Polymeric nanoparticles for increased oral bioavailability and rapid absorption using celecoxib as a model of a low-solubility, high-permeability drug.","volume":"29","author":"Morgen","year":"2012","journal-title":"Pharm. Res."},{"key":"B128","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejmech.2014.04.050","article-title":"Multifunctional nanoliposomes with curcumin\u2013lipid derivative and brain targeting functionality with potential applications for alzheimer disease.","volume":"80","author":"Mourtas","year":"2014","journal-title":"Eur. J Med. Chem."},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.57282","article-title":"Solid lipid nanoparticles: a modern formulation approach in drug delivery system.","volume":"71","author":"Mukherjee","year":"2009","journal-title":"Ind. J. Pharm. Sci."},{"key":"B130","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1021\/mp900306x","article-title":"Apoe3 mediated poly (butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model.","volume":"7","author":"Mulik","year":"2010","journal-title":"Mol. Pharm."},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.2741\/3795","article-title":"Recent developments in lipid-based pharmaceutical nanocarriers.","volume":"16","author":"Musacchio","year":"2011","journal-title":"Front. Biosci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1517\/17425247.2013.762354","article-title":"Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB.","volume":"10","author":"Nagpal","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"B133","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1016\/j.biomaterials.2013.12.090","article-title":"Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.","volume":"35","author":"Naksuriya","year":"2014","journal-title":"Biomaterials"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.7150\/thno.23734","article-title":"Localized delivery of curcumin into brain with polysorbate 80-modified cerasomes by ultrasound-targeted microbubble destruction for improved parkinson\u2019s disease therapy.","volume":"8","author":"Nisi Zhang","year":"2018","journal-title":"Theranostics"},{"key":"B135","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jconrel.2012.03.026","article-title":"Therapeutics, imaging and toxicity of nanomaterials in the central nervous system.","volume":"161","author":"Nunes","year":"2012","journal-title":"J. Control Rel."},{"key":"B136","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jocit.2017.12.001","article-title":"A review on nanotechnology based innovations in diagnosis and treatment of multiple sclerosis.","volume":"4","author":"Ojha","year":"2018","journal-title":"J. Cell Immunother."},{"key":"B137","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/jps.22299","article-title":"Development of inhalable nanocrystalline solid dispersion of tranilast for airway inflammatory diseases.","volume":"100","author":"Onoue","year":"","journal-title":"J. Pharm. Sci."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s11095-011-0379-8","article-title":"Inhalable sustained-release formulation of glucagon: in vitro amyloidogenic and inhalation properties, and in vivo absorption and bioactivity.","volume":"28","author":"Onoue","year":"","journal-title":"Pharm. Res."},{"key":"B139","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ejps.2013.05.014","article-title":"Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects.","volume":"49","author":"Onoue","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/jps.21964","article-title":"Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability.","volume":"99","author":"Onoue","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ejps.2012.03.015","article-title":"Novel solid self-emulsifying drug delivery system of coenzyme Q10 with improved photochemical and pharmacokinetic behaviors.","volume":"46","author":"Onoue","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2147\/IJN.S38378","article-title":"Nanodrugs: pharmacokinetics and safety.","volume":"9","author":"Onoue","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"B143","author":"\u00d6zdemir","year":"2017","journal-title":"Nanotechnology Methods for Neurological Diseases and Brain Tumors: Drug Delivery Across the Blood\u2013Brain Barrier."},{"key":"B144","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-3-319-57696-1_2","article-title":"Nanocarriers as cns drug delivery systems for enhanced neuroprotection","author":"Ozkizilcik","year":"2017","journal-title":"Drug and Gene Delivery to the Central Nervous System for Neuroprotection"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1016\/j.peptides.2006.04.022","article-title":"Pegylated phospholipid nanomicelles interact with \u03b2-amyloid (1\u201342) and mitigate its \u03b2-sheet formation, aggregation and neurotoxicity in vitro.","volume":"27","author":"Pai","year":"2006","journal-title":"Peptides"},{"key":"B146","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.1002\/chem.201400079","article-title":"Inhibition of amyloid fibril growth and dissolution of amyloid fibrils by curcumin\u2013gold nanoparticles.","volume":"20","author":"Palmal","year":"2014","journal-title":"Chemistry"},{"key":"B147","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ijpharm.2005.05.027","article-title":"Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery.","volume":"301","author":"Pandey","year":"2005","journal-title":"Int. J. Pharm."},{"key":"B148","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/s0169-409x(98)00087-88","article-title":"Vector-mediated drug delivery to the brain.","volume":"36","author":"Pardridge","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B149","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.addr.2007.03.008","article-title":"Shrna and sirna delivery to the brain.","volume":"59","author":"Pardridge","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood\u2013brain barrier.","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B151","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1080\/10717544.2017","article-title":"Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro\/in vivo evaluation.","volume":"24","author":"Parikh","year":"2017","journal-title":"Drug Deliv."},{"key":"B152","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.progpolymsci.2007.09.003","article-title":"Polymeric nanomedicine for cancer therapy.","volume":"33","author":"Park","year":"2008","journal-title":"Prog. Polym.Sci."},{"key":"B153","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nrm2122","article-title":"The multiple faces of caveolae.","volume":"8","author":"Parton","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1208\/s12249-009-9287-9281","article-title":"Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery.","volume":"10","author":"Pathak","year":"2009","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"B155","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/187221109787158355","article-title":"Cns drug delivery systems: novel approaches. Recent Pat.","volume":"3","author":"Pathan","year":"2009","journal-title":"Drug Deliv. Formul."},{"key":"B156","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/bit.24889","article-title":"Laser exposure of gold nanorods can increase neuronal cell outgrowth.","volume":"110","author":"Paviolo","year":"2013","journal-title":"Biotechnol. Bioeng."},{"key":"B157","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/cns.12159","article-title":"Therapeutic time window and dose dependence of xenon delivered via echogenic liposomes for neuroprotection in stroke.","volume":"19","author":"Peng","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"B158","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijpharm.2003.11.032","article-title":"Micellar solutions of triblock copolymer surfactants with pilocarpine.","volume":"272","author":"Pepic","year":"2004","journal-title":"Int. J. Pharm."},{"key":"B159","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s11095-007-9445-9447","article-title":"A novel solid-in-oil nanosuspension for transdermal delivery of diclofenac sodium.","volume":"25","author":"Piao","year":"2008","journal-title":"Pharm. Res."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1166\/jnn.2007.330","article-title":"Effects of hydrated forms of c60 fullerene on amyloid \u03b2-peptide fibrillization in vitro and performance of the cognitive task.","volume":"7","author":"Podolski","year":"2007","journal-title":"J. Nanosci. Nanotechnol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"16962","DOI":"10.1039\/c8nr04073g","article-title":"Treatment of neurodegenerative disorders through the blood\u2013brain barrier using nanocarriers.","volume":"10","author":"Poovaiah","year":"2018","journal-title":"Nanoscale"},{"key":"B162","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1021\/mp8002489","article-title":"Dendimermediated solubilization, formulation development and in vitro-in vivo assessment of piroxicam.","volume":"6","author":"Prajapati","year":"2009","journal-title":"Mol. Pharm."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1126\/science.1171004","article-title":"Conserved functions of membrane active gtpases in coated vesicle formation.","volume":"325","author":"Pucadyil","year":"2009","journal-title":"Science"},{"key":"B164","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2174\/157016311795563866","article-title":"Current advances in delivery of biotherapeutics across the blood-brain barrier.","volume":"8","author":"Rajadhyaksha","year":"2011","journal-title":"Curr. Drug Discov. Technol."},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S30721","article-title":"Liposomes and nanotechnology in drug development: focus on neurological targets.","volume":"8","author":"Ramos-Cabrer","year":"2013","journal-title":"Int. J Nanomed."},{"key":"B166","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1042\/BJ20080474","article-title":"Focusing on clathrin-mediated endocytosis.","volume":"412","author":"Rappoport","year":"2008","journal-title":"Biochem. J."},{"key":"B167","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/JAD-2010-101374","article-title":"Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (nanocurc) in the neuronal cell culture and animal model: implications for alzheimer\u2019s disease.","volume":"23","author":"Ray","year":"2011","journal-title":"J. Alzheimer Dis."},{"key":"B168","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1358\/dof.2004.029.01.872585","article-title":"Novel delivery systems for drug targeting to the brain.","volume":"29","author":"Reddy","year":"2004","journal-title":"Drugs Future"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj060323","article-title":"Etoposideincorporated tripalmitin nanoparticles with different surface charge: formulation, characterization, radiolabeling, and biodistribution studies.","volume":"6","author":"Reddy","year":"2004","journal-title":"AAPS J."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.nano.2013.12.008","article-title":"The orientation of the neuronal growth process can be directed via magnetic nanoparticles under an applied magnetic field.","volume":"10","author":"Riggio","year":"2014","journal-title":"Nanomed. Nanotechnol."},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S28460","article-title":"Poly-l-lysine-coated magnetic nanoparticles as intracellular actuators for neural guidance.","volume":"7","author":"Riggio","year":"2012","journal-title":"Int. J Nanomed."},{"key":"B172","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: a statement for healthcare professionals from the american heart association\/american stroke association.","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"key":"B173","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijpharm.2013.07.07","article-title":"Poly (amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.","volume":"456","author":"Sadekar","year":"2013","journal-title":"Int. J. Pharm."},{"key":"B174","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.nano.2011.05.016","article-title":"Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging.","volume":"8","author":"Sahoo","year":"2017","journal-title":"Nanomedicine"},{"key":"B175","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.bbrc.2015.08.023","article-title":"Regulatory aspects on nanomedicines.","volume":"468","author":"Sainz","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B176","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3109\/10717544.2011.644349","article-title":"Carbamazepine mucoadhesive nanoemulgel (mneg) as brain targeting delivery system via the olfactory mucosa.","volume":"19","author":"Samia","year":"2012","journal-title":"Drug Deliv."},{"key":"B177","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1227\/01.neu.0000318159.21731.cf","article-title":"Glioma extent of resection and its impact on patient outcome.","volume":"62","author":"Sanai","year":"2008","journal-title":"Neurosurgery"},{"key":"B178","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s12017-013-8261-y","article-title":"Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of huntington\u2019s disease.","volume":"16","author":"Sandhir","year":"2014","journal-title":"Neuromol. Med."},{"key":"B179","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/156720105774370267","article-title":"Engineering of nanoemulsions for drug delivery.","volume":"2","author":"Sarker","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3390\/mi8090262","article-title":"Stroke management: an emerging role of nanotechnology.","volume":"8","author":"Sarmah","year":"2017","journal-title":"Micromachines"},{"key":"B181","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1093\/brain\/awg176","article-title":"Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis.","volume":"126","author":"Schmidt","year":"2003","journal-title":"Brain"},{"key":"B182","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bbrc.2006.01.129","article-title":"Cerium and yttrium oxide nanoparticles are neuroprotective.","volume":"342","author":"Schubert","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B183","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s13346-013-0133-133","article-title":"Nanotechnology for cns delivery of bio-therapeutic agents.","volume":"3","author":"Shah","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"key":"B184","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/jac\/dkh411","article-title":"Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral\/aerosolized antitubercular drug carriers for treatment of tuberculosis.","volume":"54","author":"Sharma","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"B185","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0079-6123(06)62013-X","article-title":"Nanoparticles aggravate heat stress induced cognitive deficits, blood\u2013brain barrier disruption, edema formation and brain pathology.","volume":"162","author":"Sharma","year":"2007","journal-title":"Prog. Brain Res."},{"key":"B186","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1021\/acs.bioconjchem.7b00569","article-title":"Activated microglia targeting dendrimer\u2013minocycline conjugate as therapeutics for neuroinflammation.","volume":"28","author":"Sharma","year":"2017","journal-title":"Bioconjugate Chem."},{"key":"B187","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijpharm.2010.07.044","article-title":"Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.","volume":"399","author":"Shegokar","year":"2010","journal-title":"Int. J. Pharm."},{"key":"B188","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.surneu.2004.06.008","article-title":"Nanotechnology approaches for the regeneration and neuroprotection of the central nervous system.","volume":"63","author":"Silva","year":"2005","journal-title":"Surg. Neurol."},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-9-S3-S4","article-title":"Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the cns.","volume":"9","author":"Silva","year":"2008","journal-title":"BMC Neurosci."},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/160830","article-title":"Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.","volume":"2012","author":"Singh","year":"2012","journal-title":"Autoimmune Dis."},{"key":"B191","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1146\/annurev.publhealth.23.100901.140525","article-title":"The public health impact of alzheimer\u2019s disease, 2000\u20132050: potential implication of treatment advances.","volume":"23","author":"Sloane","year":"2002","journal-title":"Annu. Rev. Publ. Health"},{"key":"B192","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/10611860701725381","article-title":"Transferrin-conjugated liposomal system for improved delivery of 5-fluorouracil to brain.","volume":"16","author":"Soni","year":"2008","journal-title":"J. Drug Target"},{"key":"B193","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2174\/138920021608151107125049","article-title":"Applications of nanotechnology in diagnostics and therapeutics of alzheimer\u2019s and parkinson\u2019s disease.","volume":"16","author":"Soursou","year":"2015","journal-title":"Curr. Drug Metab."},{"key":"B194","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1023\/b:pham.0000016235.32639.23","article-title":"Solubilizing excipients in oral and injectable formulations.","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm. Res."},{"key":"B195","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1208\/s12249-013-9924-9926","article-title":"Liquid proliposomes of nimodipine drug delivery system: preparation, characterization, and pharmacokinetics.","volume":"14","author":"Sun","year":"2013","journal-title":"AAAPS Pharm. Sci. Tech."},{"key":"B196","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jconrel.2010.10.034","article-title":"Nanonization of megestrol acetate by laser fragmentation in aqueous milieu.","volume":"149","author":"Sylvestre","year":"2011","journal-title":"J. Control Rel."},{"key":"B197","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3109\/09687688.2014.937468","article-title":"The blood-brain barrier: structure, function and therapeutic approaches to cross it.","volume":"31","author":"Tajes","year":"2014","journal-title":"Mol. Membr. Biol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neuroscience.2012.06.060","article-title":"Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke-and tissue plasminogen activator-related brain damages in mice.","volume":"221","author":"Takamiya","year":"2012","journal-title":"Neuroscience"},{"key":"B199","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.nano.2011.06.015","article-title":"Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the alzheimer\u2019s a\u03b2 peptide.","volume":"7","author":"Taylor","year":"2011","journal-title":"Nanomed. Nanotechnol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jconrel.2006.03.004","article-title":"Prolonged blood concentration of prednisolone after intravenous injection of liposomal palmitoyl prednisolone.","volume":"112","author":"Teshima","year":"2006","journal-title":"J. Control Rel."},{"key":"B201","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1208\/s12248-012-9433-9437","article-title":"Supersaturated self-nanoemulsifying drug delivery systems (SuperSNEDDS) enhance the bioavailability of the poorly water-soluble drug simvastatin in dogs.","volume":"15","author":"Thomas","year":"2013","journal-title":"AAPS J."},{"key":"B202","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jconrel.2012.02.027","article-title":"In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS).","volume":"160","author":"Thomas","year":"2012","journal-title":"J. Control Rel."},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S16570","article-title":"Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles.","volume":"6","author":"Tian","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"B204","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1166\/jnn.2006.440","article-title":"Improved oral delivery of paclitaxel following administration in nanoemulsion formulations.","volume":"6","author":"Tiwari","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1021\/nn405077y","article-title":"Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in alzheimer\u2019s disease model via canonical wnt\/\u03b2-catenin pathway.","volume":"8","author":"Tiwari","year":"2013","journal-title":"ACS Nano"},{"key":"B206","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.progpolymsci.2005.01.007","article-title":"Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry.","volume":"30","author":"Tomalia","year":"2005","journal-title":"Prog. Polym. Sci."},{"key":"B207","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2174\/138161202339587.1","article-title":"Lipid formulation as a drug carrier for drug delivery.","volume":"8","author":"Tomii","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-006-9132-9130","article-title":"Micellar nanocarriers: pharmaceutical perspectives.","volume":"24","author":"Torchilin","year":"2007","journal-title":"Pharm. Res."},{"key":"B209","doi-asserted-by":"publisher","first-page":"142","DOI":"10.7324\/JAPS.2013.3924","article-title":"Dendrimers and their applications as novel drug delivery carriers.","volume":"3","author":"Tripathy","year":"2013","journal-title":"J. Appl. Pharm. Sci."},{"key":"B210","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.addr.2007.11.007","article-title":"Clinical toxicities of nanocarrier systems.","volume":"60","author":"Vega-Villa","year":"2008","journal-title":"Adv. Drug Deliv Rev."},{"key":"B211","first-page":"742","article-title":"Progress in nanomedicine: approved and investigational nanodrugs.","volume":"42","author":"Ventola","year":"2017","journal-title":"P T"},{"key":"B212","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jconrel.2014.01.004","article-title":"Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution.","volume":"174","author":"Vilella","year":"2014","journal-title":"J. Control Rel."},{"key":"B213","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1021\/bc034164r","article-title":"Nanogels for oligonucleotide delivery to the brain.","volume":"15","author":"Vinogradov","year":"2004","journal-title":"Bioconjugate Chem."},{"key":"B214","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2013.07.032","article-title":"Bioengineered sequential growth factor delivery stimulates brain tissue regeneration after stroke.","volume":"172","author":"Wang","year":"2013","journal-title":"J. Control Rel."},{"key":"B215","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijpharm.2005.10.030","article-title":"Preparation of camptothecin-loaded polymeric micelles, and evaluation of their incorporation, and circulation stability.","volume":"308","author":"Watanabe","year":"2006","journal-title":"Int. J. Pharm."},{"key":"B216","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.brainres.2008.01.039","article-title":"Poly (n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat alzheimer\u2019s disease.","volume":"1200","author":"Wilson","year":"2008","journal-title":"Brain Res."},{"key":"B217","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s11910-011-0197-8","article-title":"An update on gene therapy in parkinson\u2019s disease.","volume":"11","author":"Witt","year":"2011","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B218","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jconrel.2011.08.017","article-title":"Transport of drugs across the blood\u2013brain barrier by nanoparticles.","volume":"161","author":"Wohlfart","year":"2012","journal-title":"J. Control Rel."},{"key":"B219","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.addr.2007.04.008","article-title":"Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.","volume":"59","author":"Wong","year":"2007","journal-title":"Adv. Drug deliv. Rev."},{"key":"B220","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.addr.2011.10.007","article-title":"Nanotechnological advances for the delivery of cns therapeutics.","volume":"64","author":"Wong","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B221","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: transport\/absorption\/elimination interplay and development of a biopharmaceutics drug disposition classification system.","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm. Res."},{"key":"B222","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s11095-010-0200-0","article-title":"Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats.","volume":"27","author":"Xia","year":"2010","journal-title":"Pharm. Res."},{"key":"B223","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/jcbfm.2012.48","article-title":"Delivering minocycline into brain endothelial cells with liposome-based technology.","volume":"32","author":"Xing","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B224","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/cn400182z","article-title":"Dendrimer advances for the central nervous system delivery of therapeutics.","volume":"5","author":"Xu","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"B225","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/cn400182z","article-title":"Dendrimer advances for the central nervous system delivery of therapeutics.","volume":"5","author":"Xu","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"B226","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid \u03b2 oligomers and fibrils, binds plaques, and reduces amyloid in vivo.","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B227","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.nano.2009.11.007","article-title":"Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating alzheimer disease.","volume":"6","author":"Yang","year":"2010","journal-title":"Nanomedicine"},{"key":"B228","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s00109-019-01843-1844","article-title":"Co-delivery of GOLPH3 siRNA and gefitinib by cationic lipid-PLGA nanoparticles improves EGFR-targeted therapy for glioma.","volume":"11","author":"Ye","year":"2019","journal-title":"J. Mol. Med."},{"key":"B229","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/jcbfm.2014.220","article-title":"Systemically administered brain-targeted nanoparticles transport peptides across the blood\u2014brain barrier and provide neuroprotection.","volume":"35","author":"Yemisci","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S34588","article-title":"Plausible antioxidant biomechanics and anticonvulsant pharmacological activity of brain-targeted \u03b2-carotene nanoparticles.","volume":"7","author":"Yusuf","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"B231","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1750-3639.2008.00231.x","article-title":"Molecular changes in white matter adjacent to an active demyelinating lesion in early multiple sclerosis.","volume":"19","author":"Zeis","year":"2009","journal-title":"Brain Pathol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications, and developments.","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"B233","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijpharm.2006.07.026","article-title":"Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.","volume":"327","author":"Zhang","year":"2006","journal-title":"Int. J. Pharm."},{"key":"B234","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1021\/mp200600t","article-title":"Transferrin-modified c[rgdfk]-paclitaxel loaded hybrid micelle for sequential blood-brain barrier penetration and glioma targeting therapy.","volume":"9","author":"Zhang","year":"2012","journal-title":"Mol. Pharm."},{"key":"B235","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/10430340360464660","article-title":"Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.","volume":"14","author":"Zhang","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"B236","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/hum.2010.111","article-title":"Postacute ischemia vascular endothelial growth factor transfer by transferrin-targeted liposomes attenuates ischemic brain injury after experimental stroke in rats.","volume":"22","author":"Zhao","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"B237","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.biomaterials.2009.10.044","article-title":"Partly pegylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of pegylation degree and drug conjugation style.","volume":"31","author":"Zhu","year":"","journal-title":"Biomaterials"},{"key":"B238","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11095-010-0217-4","article-title":"Pegylated pamam dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation.","volume":"27","author":"Zhu","year":"","journal-title":"Pharm. Res."},{"key":"B239","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1021\/mp500057n","article-title":"Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals.","volume":"11","author":"Zong","year":"2014","journal-title":"Mol. Pharm."},{"key":"B240","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.brainres.2010.05.071","article-title":"Efficacy of tyrosine hydroxylase gene modified neural stem cells derived from bone marrow on parkinson\u2019s disease\u2013a rat model study.","volume":"1346","author":"Zou","year":"2010","journal-title":"Brain Res."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00494\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T11:41:38Z","timestamp":1666870898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00494\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":240,"alternative-id":["10.3389\/fnins.2020.00494"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2020.00494","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"article-number":"494"}}